Meld u aan

Elodie Long-Mira

Laboratory of Clinical and Experimental Pathology,
Pasteur Hospital,
Hospital University Federation OncoAge,
Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284),
Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge

Université Côte d’Azur

BIOGRAPHY

Elodie Long-Mira has not added Biography.

If you are Elodie Long-Mira and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.

Oncotarget Apr, 2017 | Pubmed ID: 28212540

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Cancers Mar, 2018 | Pubmed ID: 29534030

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.

Cancers Mar, 2018 | Pubmed ID: 29561830

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.

Cancers Apr, 2018 | Pubmed ID: 29621151

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Cancers Jun, 2018 | Pubmed ID: 29891792

[Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction].

Annales de pathologie Jun, 2018 | Pubmed ID: 29929740

[Carcinoma of unknown primary. Case no. 6].

Annales de pathologie Jun, 2018 | Pubmed ID: 29929745

[Carcinoma of unknown primary. Case no. 5].

Annales de pathologie Jun, 2018 | Pubmed ID: 29929746

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Cancers Jun, 2018 | Pubmed ID: 29966305

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.

Cancers Sep, 2018 | Pubmed ID: 30216999

INSTITUTIONS

Université Côte d’Azur

JOVE ARTICLES

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Marius Ilié^1,2,3,

Mélanie Ngo-Mai¹,

Elodie Long-Mira^1,2,

Sandra Lassalle^1,2,

Catherine Butori¹,

Coraline Bence¹,

Marame Hamila¹,

Véronique Hofman^1,2,3,

Paul Hofman^1,2,3

¹Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur,

²Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur,

³Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur

Cancer Research

Privacy

Gebruiksvoorwaarden

Beleid

Neem contact met ons op.

Aanbevelen aan bibliotheek

JoVE Nieuwsbrieven

Onderzoek

JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren

Onderwijs

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Faculteitssite

Auteurs

Overzicht
Publicatieproces
Redactieraad
Omvang en beleid
Collegiale beoordeling
VEELGESTELDE VRAGEN
Verzenden

Bibliothecarissen

Overzicht
Getuigenissen
Abonnementen
Toegang
Middelen
Bibliotheek Adviesraad
VEELGESTELDE VRAGEN

Over JoVE

Overzicht
Leiderschap
Blog
JoVE Help Center
JoVE Sitemap